(Pro)Renin Receptor–Mediated Activation of Mitogen-Activated Protein Kinases in Human Vascular Smooth Muscle Cells - Hypertension Research
- ️Itoh, Hiroshi
- ️Thu Nov 01 2007
Ichihara A, Kaneshiro Y, Takemitsu T, et al: Non-proteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension. Hypertension 2006; 47: 894–900.
Ichihara A, Kaneshiro Y, Takemitsu T, et al: Contribution of non-proteolytically activated prorenin in glomeruli to hypertensive renal damage. J Am Soc Nephrol 2006; 17: 2495–2503.
Ichihara A, Hayashi M, Kaneshiro Y, et al: Inhibition of diabetic nephropathy by a decoy peptide corresponding to the “handle” region for non-proteolytic activation of prorenin. J Clin Invest 2004; 114: 1128–1135.
Satofuka S, Ichihara A, Nagai N, et al: Suppression of ocular inflammation in endotoxin-induced uveitis by inhibiting nonproteolytic activation of prorenin. Invest Ophthalmol Vis Sci 2006; 47: 2686–2692.
Nguyen G, Delarue F, Burckle C, et al: Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 2002; 109: 1417–1427.
Schefe J, Funke-Kaiser H, Jost A, et al: Signal transduction of the renin/prorenin receptor. J Hypertens 2005; 23: S354 ( Abstract).
Huang Y, Wongamorntham S, Kasting J, et al: Renin increases mesangial cell transforming growth factor-β1 and matrix proteins through receptor-mediated angiotensin II–independent mechanisms. Kidney Int 2006; 69: 105–113.
Ichihara A, Suzuki F, Nakagawa T, Kaneshiro Y, et al: Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor deficient mice. J Am Soc Nephrol 2006; 17: 1950–1961.
Saris J, 'T Hoen P, Garrelds I, et al: Prorenin induces intracellular signaling in cardiomyocytes independently of angiotensin II. Hypertension 2006; 48: 564–571.
Poorman R, Palermo D, Post L, et al: Isolation and characterization of native human renin derived from Chinese hamster ovary cells. Proteins 1986; 1: 139–145.
Li P-G, Xu J-W, Ikeda K, et al: Caffeic acid inhibits vascular smooth muscle cell proliferation induced by angiotensin II in stroke-prone spontaneously hypertensive rats. Hypertens Res 2005; 28: 369–377.
Kaneshiro Y, Ichihara A, Takemitsu T, et al: Increased expression of cyclooxygenase-2 in renal cortex of human-prorenin-receptor–gene transgenic rats. Kidney Int 2006; 70: 641–646.
Suzuki F, Hayakawa M, Nakagawa T, et al: Human prorenin has “gate and handle” regions for its non-proteolytic activation. J Biol Chem 2003; 278: 22217–22222.
Catanzaro DF : Physiological relevance of renin/prorenin binding and uptake. Hypertens Res 2005; 28: 97–105.
Eguchi S, Inagami T : Signal transduction of angiotensin II type 1 receptor through receptor tyrosine kinase. Regul Pept 2000; 91: 13–20.
Li P-G, Xu J-W, Ikeda K, et al: Caffeic acid inhibits vascular smooth muscle cell proliferation induced by angiotensin II in stroke-prone spontaneously hypertensive rats. Hypertens Res 2005; 28: 369–377.
Marshall C : Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal–regulated kinase activation. Cell 1995; 80: 179–185.
Burckle C, Jan Danser A, Muller D, et al: Elevated blood pressure and heart rate in human renin receptor transgenic rats. Hypertension 2006; 47: 1–5.
Niimura F, Labosky P, Kakuchi J, et al: Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation. J Clin Invest 1995; 96: 2947–2954.
Veniant M, Menard J, Bruneval P, et al: Vascular damage without hypertension in transgenic rats expressing prorenin exclusively in the liver. J Clin Invest 1996; 98: 1966–1970.